REBELS THERAPEUTICS
Live / Applied — New application — not yet assigned to an examiner (as of 24 Sept 2026)
What this means for you
Not registered yet, but its 24 Sept 2026 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 50127778
- Mark type
- Design + words
- Filed
- 24 Sept 2026
- Attorney of record
- Aaron D. Hendelman
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for use in the treatment of cancer and oncological disorders, cardiovascular diseases, metabolic and endocrine disorders, neurological and central nervous system disorders, autoimmune and inflammatory diseases, infectious diseases, respiratory diseases, gastrointestinal disorders, dermatological disorders, musculoskeletal disorders, hematological disorders, renal and urological disorders, ophthalmic disorders, and rare and genetic diseases; biopharmaceutical preparations; biological preparations for medical purposes; gene therapy preparations; cell therapy preparations; vaccines
- Class 042 — Scientific and technological services: Scientific research services in the field of pharmaceuticals and biotechnology; drug discovery services; research and development of pharmaceutical and biopharmaceutical products; biotechnological research services; clinical trial design services for others; providing information in the field of pharmaceutical research and development
Owner
- Rebels Therapeutics, Inc., Los Angeles, CA, US
Prosecution history
- 24 Sept 2026 — APPLICATION FILING RECEIPT MAILED
- 24 Sept 2026 — NEW APPLICATION ENTERED